Skip to main content
LLY
NYSE Life Sciences

Lilly's Oral GLP-1 Wins China Approval, First Pill in a Market Seen at $4.5B

Tom Rudovsky · Reported by Benzinga
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1,452.695
Mkt Cap
$1.352T
52W Low
$850.51
52W High
$1,460
52W Position info
71% above low
Off High info
at 52W high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

LLY sits 71% above its 52-week low of $850.51.

Summary

China approved orforglipron for chronic weight management, making Lilly the first company with a GLP-1 obesity pill in the country — previously only injectables were cleared there. JP Morgan projects China's GLP-1 weight-loss market at 30 billion yuan ($4.5 billion) in five to seven years, versus roughly 3-4 billion yuan ($449.75 million-$599.66 million) today. The edge is timing: Lilly gets an oral option in front of Novo Nordisk, Pfizer and Innovent in the world's second-largest pharma market. Pfizer already has its ecnoglutide injection approved in China since March, so the competitive field is filling in fast. Lilly shares are up 33.74% year-to-date and traded at $1,462.18 premarket, near the 52-week high of $1,460.

At the time of this announcement, LLY was trading at $1,452.70 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.4T. The 52-week trading range was $850.51 to $1,460.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,429.45 info
Change: -$18.40 (-1%) info
Market Cap: $1.343T info
LLY
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1,411.12
Real-time Price: $1,429.45 info
Change: +$18.33 (+1%) info
Market Cap: $1.343T info
LLY
Nov 09, 2026, 10:23 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1,394.15
Real-time Price: $1,429.45 info
Change: +$35.30 (+3%) info
Market Cap: $1.343T info
LLY
Nov 06, 2026, 6:45 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,346.00
Real-time Price: $1,429.45 info
Change: +$83.45 (+6%) info
Market Cap: $1.343T info
LLY
Nov 04, 2026, 1:53 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,416.54
Real-time Price: $1,429.45 info
Change: +$12.91 (+0.91%) info
Market Cap: $1.343T info